Metformin pretreatment enhanced learning and memory in cerebral forebrain ischaemia: the role of the AMPK/BDNF/P70SK signalling pathway

Abstract

Context Metformin induced AMP-activated protein kinase (AMPK) and protected neurons in cerebral ischaemia. Objective This study examined pretreatment with metformin and activation of AMPK in molecular and behavioral levels associated with memory. Materials and methods Rats were pretreated with metformin (200 mg/kg) for 2 weeks and 4-vessels occlusion global cerebral ischaemia was induced. Three days after ischaemia, memory improvement was done by passive avoidance task and neurological scores were evaluated. The amount of Brain-Derived Neurotropic Factor (BDNF) and phosphorylated and total P70S6 kinase (P70S6K) were measured. Results Pretreatment with metformin (met) in the met + ischaemia/reperfusion (I/R) group reduced latency time for enter to dark chamber compared with the sham group (p50.001) and increased latency time compared with the I/R group (p50.001). Injection of Compound C (CC) (as an AMPK inhibitor) concomitant with metformin reduced latency time in I/R rats compared with the I/R + met group (p50.05). Neurological scores were reduced in met treated rats compared with the sham group. Pretreatment with metformin in I/R animals reduced levels of pro-BDNF compared with the I/R group (p50.001) but increased that compared with the sham group (p50.001). The level of pro-BDNF decreased in the met + CC + I/R group compared with the met + I/R group (p50.01). Pretreatment with metformin in I/R animals significantly increased P70S6K compared with the I/R group (p50.001). Conclusion Short-term memory in ischaemic rats treated with metformin increased step-through latency; sensory-motor evaluation was applied and a group of ischaemia rats that were pretreated with metformin showed high levels of BDNF, P70S6K that seemed to be due to increasing AMPK. ARTICLE HISTORY

The Effects of Metformin on Obesity-Induced Dysfunctional Retinas

“…However, metformin successfully acted as a protective drug in various disease models when used to pretreat animals prior to the induction of diseases, including acute kidney injury 44 and cerebral forebrain ischemia. 45,46 Thus, it is possible that metformin is more beneficial if it is given at an earlier, prediabetic stage as a “preventive” strategy rather than as a “treatment” for diabetic retinas.…”

The protective effect of betulinic acid on microvascular responsivity and protein expression in alzheimer disease induced by cerebral micro‐injection of beta‐amyloid and streptozotocin

“…Skim milk 5% was used to block the membrane (overnight exposure), and HRP‐conjugated IgG rabbit polyclonal anti‐mouse secondary antibody was applied to labeled proteins during 1 hour of shacking (dilution 1: 2000; Abcam, USA). Using an Electrochemiluminescence kit (ECL), protein bands appeared in Bio‐Rad Gel Doc system and analyzed with IMAGE J software in the last step of the Western blot procedure …”

Metformin ameliorates the age‐related changes of d‐galactose administration in ovariectomized mice

“…Consistently, previous reports have shown that Met could elevate the BDNF level. Pretreatment of rats with Met for 2 weeks improved the neurological scores and BDNF level in global cerebral ischemia . In a recent study, the antioxidant and antisenescence effects of Met were investigated in mouse olfactory ensheathing cells.…”